INM · InMed Pharmaceuticals Inc. · Exempt Offerings
$1.33
-0.02 (-1.48%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Sep 9, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.”View the 10-K filed Sep 9, 2026
Market Cap
$7.58M
Shares
5.49M
Volume · Oct 2
28.34K
Avg daily vol (3M)
916.81K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.